Stockreport

Altasciences Chosen by Virpax Pharmaceuticals, Inc. to Conduct First-in-Human Study of Epoladerm™ for Chronic Pain Associated with Osteoarthritis of the Knee

Virpax Pharmaceuticals, Inc.  (VRPX) 
PDF LAVAL, Quebec--(BUSINESS WIRE)--Altasciences is pleased to have been chosen by Virpax® Pharmaceuticals, Inc. (“Virpax”) (NASDAQ:VRPX) to conduct a first-in-human stu [Read more]